Sales of Mounjaro weight loss jab to UK suspended as pharmacies hit by shortage ahead of price hike
Weight loss drug Mounjaro manufacturer, users began to stock up on Monday with the expectation of a price increase after the beginning of Jab’s sales to the UK wholesalers suspended.
The increase in demand caused famine in large pharmacies, including the boots of high street companies, the Lloyds pharmacy and the super physician.
Mounjaro’s US manufacturer Eli Lilly He announced that the drug in the UK will increase the price of 170 percent as of September.
The price increase, which will increase the highest one -month highest dose supply from £ 122 to £ 330, came after US President Donald Trump called on the United States to increase the prices of drug producers abroad and reduce them at home.
Eli Lilly told two British wholesalers to stop receiving orders with “unprecedented demand” until Monday.
On social media, many users, the National Pharmacy Association (NPA) and Eli Lilly’nin warnings that they did not enter the collective sequence, despite the first price increase to avoid the drug said they stocked the drug.
On Wednesday, Superdrug’s website Mounjaro said that Mounjaro was not in stock because of a national famine ”. Company toldIndependent: “We are currently working hard to fulfill all the orders given for Mounjaro and we hope to start accepting new customer orders next week.
“Due to extremely high demand throughout the country, we are experiencing delays with Mounjaro stock. In order to ensure the continuity of care, we prioritize the drug orders of current super -plant patients currently using our weight loss services.”
Lloyds Pharmacy said on the website that high -dosage items of 10mg, 12.5mg and 15mg are not in stock for new recipes, Boots Online Doctor showed that 7.5mg, 10mg, 12.5mg or 15mg PENS.
Before users rise to higher dosages, usually starts at a 2.5 mg dose per week as part of a weight loss plan.
Well, the second largest pharmacy chain in the UK, said Wel Pharmacy, Mounjaro, because of the increase in demand, “intermittent” from wholesalers, he said.
The company’s clinical product and innovation manager Mital Thakrar, Independent: “We are working hard with our wholesalers and manufacturers to maintain stock supply in well stores and we are currently staying in Mounjaro stock.”
The situation also affected online pharmacies. Pharmacy 2U said that after the announcement of the price increase, it experienced a “significant short -term fluctuation, but the increase calmed down and prioritized existing patients.
Simple online pharmacy, Mounjaro’yu paused to sell to new patients, and at the same time to stop collective sales of sales per patient with a four -week supply, he said. He said that there was sufficient supply in all dosages to meet his prescriptions again.
Pharmacy said that more people ordered a cheaper alternative to opponent weight loss drug wegovy. Wegovy, who cost £ 85 per month, is recommended for a week between the two products.
Last week, Wegovy’s sales in a weight loss supplier increased by 2,600 percent after Mounjaro price increase.
Simple Online Healthcare’s Chief Clinical Officer Abdal Alvi, Wegovy and Mounjaro, including all GLP-1 drugs, said that the increase in price increased by 400 percent, he said.
The increase in demand led to concerns in the pharmacy industry, including the NPA, which he said that he was aware of “closing or preventing orders for higher doses” before the wholesalers’ price increase.
Chair Olivier Picard added that collective purchase may have a significant impact on the supply, as well as a potential risk for patient safety by a possible lack of regular controls by the seller as part of the weight loss management.
Patients urged the UK to avoid unlicensed sellers who could sell counterfeit drugs that do not meet safety standards.
Men Picard, who runs his own pharmacy, said, “The situation is now terrible. I have patients from online pharmacies and other brick and mortar pharmacies, calling, ‘Did you get it? I need a supply and my supplier has no stock’.
“I think wholesalers are completely overwhelmed by the demand of people trying to buy Mounjaro.”
Eli Lilly said it helps to manage the supply and access the patient for the providers who order stock.
A spokesman told Independent: “There are legal protections implemented by the health products regulatory agency to prevent inappropriate stock of drugs by providers.
“We encourage patients to order only according to their current treatment plans to reduce the risk of localized disruption.”
The company’s decision to increase the price, as well as efforts to highlight the prices more closely with other European markets, has been aligned more closely to keep political pressure from the United States low for Americans.
